Shares of Oklo (NYSE: OKLO) surged more than 12% on August 25, briefly touching above $44 per share before settling back amid broader market activity.
Despite the single-day bounce, Oklo’s stock remains down more than 38% year-to-date, leaving investors who bought earlier in the year still nursing significant losses.
The small nuclear reactor company went public through a special purpose acquisition company and began trading publicly in May 2025, generating considerable market excitement around its technology.
Oklo carries a market capitalization of approximately $8 billion, a striking figure for a company that currently generates zero commercial energy income.
Its first Small Modular Reactor, the Aurora Powerhouse, is under construction at Idaho National Laboratory but is not expected to enter commercial operation for several more years.
In June, the Department of Energy’s Idaho Operations Office approved the preliminary documented safety analysis for Oklo’s first Aurora Powerhouse deployment, marking a meaningful but early regulatory milestone.
The company is burning tens of millions of dollars in operating losses annually, with second-quarter results showing a loss from operations of $124.2 million.
The net loss for the quarter reached $81.6 million, partially offset by $44.5 million in net interest and dividend income, underscoring just how far the company is from profitability.
Oklo already faced a significant regulatory setback in 2022, when the Nuclear Regulatory Commission denied its initial custom combined license application, citing gaps in safety baseline data.
With a price-to-book ratio of around 2.5, investors are currently paying $2.50 for every $1 of net assets on the company’s balance sheet, a premium that leaves little room for error.
Market enthusiasm around powering artificial intelligence data centers has fueled much of Oklo’s speculative appeal, but that same enthusiasm has contributed to extreme stock volatility.
Any negative headline involving licensing delays, technical setbacks, or a broader pullback in AI infrastructure spending could trigger sharp drawdowns in a stock already priced for long-term success.
Traditional valuation metrics offer little clarity here, since the company has no product revenue or earnings against which analysts can measure its multibillion-dollar market value.
Until Oklo has its first SMR fully approved and commercially operational, the gap between hype and tangible business reality remains the single most compelling reason to stay on the sidelines.
